Liability Risk and Insurance
NICE openness?
The National Institute of Clinical Excellence (NICE) is likely to end attempts at confidentiality of its deliberations, after
repeated leaks. Former secrecy had been driven by fears of effects on pharmaceutical industry shares but, after consultation
with the Financial Services Authority, secrecy-plus-leaks is seen as untenable, an element of transparency less harmful.